Education
About Us
Working with TipRanks
Follow Us
Cannabis Bioscience International Holdings (CBIH)
OTHER OTC:CBIH
Total Valuation
Cannabis Bioscience International Holdings has a market cap or net worth of $5.81M. The enterprise value is ―.
Market Cap$5.81M
Enterprise Value―
Share Statistics
Cannabis Bioscience International Holdings has 11,626,749,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,626,749,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Cannabis Bioscience International Holdings’s return on equity (ROE) is 0.47 and return on invested capital (ROIC) is 56.68%.
Return on Equity (ROE)0.47
Return on Assets (ROA)-17.22
Return on Invested Capital (ROIC)56.68%
Return on Capital Employed (ROCE)0.46
Revenue Per Employee151.51K
Profits Per Employee-274.41K
Employee Count2
Asset Turnover9.51
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cannabis Bioscience International Holdings is ―. Cannabis Bioscience International Holdings’s PEG ratio is 0.00062.
PE Ratio―
PS Ratio0.02
PB Ratio>-0.01
Price to Fair Value>-0.01
Price to FCF-0.02
Price to Operating Cash Flow>-0.01
PEG Ratio0.00062
Income Statement
In the last 12 months, Cannabis Bioscience International Holdings had revenue of 303.02K and earned -548.82K in profits. Earnings per share was -0.05.
Revenue303.02K
Gross Profit262.92K
Operating Income-421.37K
Pretax Income-548.82K
Net Income-548.82K
EBITDA-335.53K
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -549.34K and capital expenditures 0.00, giving a free cash flow of -549.34K billion.
Operating Cash Flow-549.34K
Free Cash Flow-549.34K
Free Cash Flow per Share>-0.01
Dividends & Yields
Cannabis Bioscience International Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.04
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Cannabis Bioscience International Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Cannabis Bioscience International Holdings as a current ratio of 0.03, with Debt / Equity ratio of -33.10%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap64.59
Net Debt to EBITDA-1.21
Interest Coverage Ratio-2.34
Taxes
In the past 12 months, Cannabis Bioscience International Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Cannabis Bioscience International Holdings EV to EBITDA ratio is -1.23, with an EV/FCF ratio of -1.26.
EV to Sales1.37
EV to EBITDA-1.23
EV to Free Cash Flow-1.26
EV to Operating Cash Flow-1.26
Balance Sheet
Cannabis Bioscience International Holdings has $223.00 in cash and marketable securities with $412.50K in debt, giving a net cash position of -$412.28K billion.
Cash & Marketable Securities$223.00
Total Debt$412.50K
Net Cash-$412.28K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.11
Margins
Gross margin is 73.11%, with operating margin of -139.05%, and net profit margin of -181.12%.
Gross Margin73.11%
Operating Margin-139.05%
Pretax Margin-181.12%
Net Profit Margin-181.12%
EBITDA Margin-110.73%
EBIT Margin-121.58%
Analyst Forecast
The average price target for Cannabis Bioscience International Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―